MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review)
- Authors:
- Jiye Liu
- Fei Zhang
- Jiahe Wang
- Yibing Wang
-
Affiliations: Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China, Department of Urology Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China - Published online on: October 18, 2023 https://doi.org/10.3892/or.2023.8648
- Article Number: 211
-
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Seguin L, Durandy M and Feral CC: Lung adenocarcinoma tumor origin: A guide for personalized medicine. Cancers (Basel). 14:17592022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF and Wong KK: Non-small-cell lung cancers: A heterogeneous set of diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Davidson MR, Gazdar AF and Clarke BE: The pivotal role of pathology in the management of lung cancer. J Thorac Dis. 5 (Suppl 5):S463–S478. 2013.PubMed/NCBI | |
|
Zito Marino F, Bianco R, Accardo M, Ronchi A, Cozzolino I, Morgillo F, Rossi G and Franco R: Molecular heterogeneity in lung cancer: From mechanisms of origin to clinical implications. Int J Med Sci. 16:981–989. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Langer CJ, Besse B, Gualberto A, Brambilla E and Soria JC: The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol. 28:5311–5320. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Iqbal MA, Arora S, Prakasam G, Calin GA and Syed MA: MicroRNA in lung cancer: Role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 70:3–20. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ishola AA, La'ah AS, Le HD, Nguyen VQ, Yang YP, Chou SJ, Tai HY, Chien CS and Wang ML: Non-coding RNA and lung cancer progression. J Chin Med. 83:8–14. 2020. | |
|
Esteller M: Non-coding RNAs in human disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, et al: MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res. 16:430–441. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y, Liu Z, Xu Q, Liu S, Xiao D and Tao Y: Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer. 19:472020. View Article : Google Scholar : PubMed/NCBI | |
|
Hanna J, Hossain GS and Kocerha J: The potential for microRNA therapeutics and clinical research. Front Genet. 10:4782019. View Article : Google Scholar : PubMed/NCBI | |
|
Li G, Fang J, Wang Y, Wang H and Sun CC: MiRNA-based therapeutic strategy in lung cancer. Curr Pharm Des. 23:6011–6018. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Agrawal N, Dasaradhi PVN, Mohmmed A, Malhotra P, Bhatnagar RK and Mukherjee SK: RNA interference: Biology, mechanism, and applications. Microbiol Mol Biol Rev. 67:657–685. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Michlewski G and Cáceres JF: Post-transcriptional control of miRNA biogenesis. RNA. 25:1–16. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Guo WT and Wang Y: Dgcr8 knockout approaches to understand microRNA functions in vitro and in vivo. Cell Mol Life Sci. 76:1697–1711. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lu TX and Rothenberg ME: MicroRNA. J Allergy Clin Immunol. 141:1202–1217. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Heyam A, Lagos D and Plevin M: Dissecting the roles of TRBP and PACT in double-stranded RNA recognition and processing of noncoding RNAs. Wiley Interdiscip Rev RNA. 6:271–289. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Linder P and Jankowsky E: From unwinding to clamping-the DEAD box RNA helicase family. Nat Rev Mol Cell Biol. 12:505–616. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Williams AE: Functional aspects of animal microRNAs. Cell Mol Life Sci. 65:545–562. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Du T and Zamore PD: microPrimer: The biogenesis and function of microRNA. Development. 132:4645–4652. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Treiber T, Treiber N and Meister G: Regulation of microRNA biogenesis and function. Thromb Haemost. 107:605–610. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ren H and Wang Q: Non-coding RNA and diabetic kidney disease. DNA Cell Biol. 40:553–567. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Gizak A, Duda P, Pielka E, McCubrey JA and Rakus D: GSK3 and miRNA in neural tissue: From brain development to neurodegenerative diseases. Biochim Biophys Acta Mol Cell Res. 1867:1186962020. View Article : Google Scholar : PubMed/NCBI | |
|
Hill M and Tran N: miRNA interplay: Mechanisms and consequences in cancer. Dis Model Mech. 14:dmm0476622021. View Article : Google Scholar : PubMed/NCBI | |
|
Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Long H, Wang Z, Chen J, Xiang T, Li Q, Diao X and Zhu B: microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu). Oncotarget. 6:38705–38718. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Han L, Huang Z, Liu Y, Ye L, Li D, Yao Z, Wang C, Zhang Y, Yang H, Tan Z, et al: MicroRNA-106a regulates autophagy-related cell death and EMT by targeting TP53INP1 in lung cancer with bone metastasis. Cell Death Dis. 12:10372021. View Article : Google Scholar : PubMed/NCBI | |
|
Luo J, Xia L, Zhang L, Zhao K and Li C: MiRNA-144-5p down-modulates CDCA3 to regulate proliferation and apoptosis of lung adenocarcinoma cells. Mutat Res. 825:1117982022. View Article : Google Scholar : PubMed/NCBI | |
|
Mo D, Yang D, Xiao X, Sun R, Huang L and Xu J: MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin. Biotechnol Lett. 39:701–710. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yin R, Zhang S, Wu Y, Fan X, Jiang F, Zhang Z, Feng D, Guo X and Xu L: microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4. Oncol Rep. 25:1747–1754. 2011.PubMed/NCBI | |
|
Zhang JX, Yang W, Wu JZ, Zhou C, Liu S, Shi HB and Zhou WZ: MicroRNA-32-5p inhibits epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting SMAD family 3. J Cancer. 12:2258–2267. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Si L and Tian H: MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3. Exp Ther Med. 16:5400–5409. 2018.PubMed/NCBI | |
|
Lu Y, Zheng W, Rao X, Du Y and Xue J: MicroRNA-9-5p facilitates lung adenocarcinoma cell malignant progression via targeting STARD13. Biochem Genet. 60:1865–1880. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu K, Lin J, Chen S and Xu Q: miR-9-5p promotes lung adenocarcinoma cell proliferation, migration and invasion by targeting ID4. Technol Cancer Res Treat. 20:153303382110485922021. View Article : Google Scholar : PubMed/NCBI | |
|
Han HS, Son SM, Yun J, Jo YN and Lee OJ: MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6. FEBS Lett. 588:3744–3750. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cao J, He Y, Liu HQ, Wang SB, Zhao BC and Cheng YS: MicroRNA 192 regulates chemo-resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl-2. Int J Clin Exp Med. 8:12397–12403. 2015.PubMed/NCBI | |
|
Ma Z, Chen G, Chen Y, Guo Z, Chai H, Tang Y, Zheng L, Wei K, Pan C, Ma Z, et al: MiR-937-3p promotes metastasis and angiogenesis and is activated by MYC in lung adenocarcinoma. Cancer Cell Int. 22:312022. View Article : Google Scholar : PubMed/NCBI | |
|
Duan L, Wang J, Zhang D, Yuan Y, Tang L, Zhou Y and Jiang X: Immune-related miRNA-195-5p inhibits the progression of lung adenocarcinoma by targeting polypyrimidine tract-binding protein 1. Front Oncol. 12:8625642022. View Article : Google Scholar : PubMed/NCBI | |
|
Bu L, Tian Y, Wen H, Jia W and Yang S: miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2. Acta Biochim Biophys Sin (Shanghai). 53:189–200. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan C, Bai R, Gao Y, Jiang X, Li S, Sun W, Li Y, Huang Z, Gong Y and Xie C: Effects of MicroRNA-195-5p on biological behaviors and radiosensitivity of lung adenocarcinoma cells via targeting HOXA10. Oxid Med Cell Longev. 2021:45222102021. View Article : Google Scholar : PubMed/NCBI | |
|
Cao X, Xue F, Chen H, Shen L, Yuan X, Yu Y, Zong Y, Zhong L and Huang F: MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2. Ann Transl Med. 10:13742022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhuang L, Shou T, Li K, Gao CL, Duan LC, Fang LZ, Zhang QY, Chen ZN, Zhang C, Yang ST and Li GF: MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and indicates poor survival and recurrence in lung adenocarcinoma. J Cell Mol Med. 21:2852–2862. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao S, Gao X, Zang S, Li Y, Feng X and Yuan X: MicroRNA-383-5p acts as a prognostic marker and inhibitor of cell proliferation in lung adenocarcinoma by cancerous inhibitor of protein phosphatase 2A. Oncol Lett. 14:3573–3579. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sato T, Shiba-Ishii A, Kim Y, Dai T, Husni RE, Hong J, Kano J, Sakashita S, Iijima T and Noguchi M: miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Cancer Sci. 108:536–542. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Pu X, Jiang H, Li W, Xu L, Wang L and Shu Y: Upregulation of the coatomer protein complex subunit beta 2 (COPB2) gene targets microRNA-335-3p in NCI-H1975 lung adenocarcinoma cells to promote cell proliferation and migration. Med Sci Monit. 26:e9183822020. View Article : Google Scholar : PubMed/NCBI | |
|
Hu WB, Wang L, Huang XR and Li F: MicroRNA-204 targets SOX4 to inhibit metastasis of lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 23:1553–1562. 2019.PubMed/NCBI | |
|
Zhou Y, Zhao M, Du Y, Liu Y, Zhao G, Ye L, Li Q, Li H, Wang X, Liu X, et al: MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin. Thorac Cancer. 10:1419–1430. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Wu G, Zhang H, Peng X, Huang B, Huang M, Ding J, Mao C and Peng C: MiR-196b promotes the invasion and migration of lung adenocarcinoma cells by targeting AQP4. Technol Cancer Res Treat. 20:15330338209858682021. View Article : Google Scholar : PubMed/NCBI | |
|
Pan L, Tang Z, Pan L and Tang R: MicroRNA-3666 inhibits lung cancer cell proliferation, migration, and invasiveness by targeting BPTF. Biochem Cell Biol. 97:415–422. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Mou X and Liu S: MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2. Biochem Biophys Res Commun. 477:521–526. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Chen Y, Jin M, Wang J, Li S, Chen Z and Yu W: MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1. Oncol Lett. 13:1451–1455. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, Xue Q, Wang D, Du M, Zhang Y and Gao S: miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1. Am J Transl Res. 7:2519–2526. 2015.PubMed/NCBI | |
|
Liu L, Bi N, Wu L, Ding X, Men Y, Zhou W, Li L, Zhang W, Shi S, Song Y and Wang L: MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma. Mol Cancer. 16:502017. View Article : Google Scholar : PubMed/NCBI | |
|
Chai Y, Xue H, Wu Y, Du X, Zhang Z, Zhang Y, Zhang L, Zhang S, Zhang Z and Xue Z: MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase. Exp Ther Med. 15:4822–4828. 2018.PubMed/NCBI | |
|
Zhu D, Gu L, Li Z, Jin W, Lu Q and Ren T: MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2. Pathol Res Pract. 215:861–872. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Wang F and Xu P: miR-590 accelerates lung adenocarcinoma migration and invasion through directly suppressing functional target OLFM4. Biomed Pharmacother. 86:466–474. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Wang Y, Zang W, Wang H, Chu H, Li P, Li M, Zhang G and Zhao G: Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells. Tumour Biol. 35:39–46. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Greenawalt EJ, Edmonds MD, Jain N, Adams CM, Mitra R and Eischen CM: Targeting of SGK1 by miR-576-3p inhibits lung adenocarcinoma migration and invasion. Mol Cancer Res. 17:289–298. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Fu Q, Li H, Zhu L, Chen W, Ruan T, Xu W and Yu X: MicroRNA-520c-3p functions as a novel tumor suppressor in lung adenocarcinoma. FEBS J. 286:2737–2752. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fan G, Xu P and Tu P: MiR-1827 functions as a tumor suppressor in lung adenocarcinoma by targeting MYC and FAM83F. J Cell Biochem. 121:1675–1689. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wu A, Yang X, Zhang B, Wang S and Li G: miR-516a-3p promotes proliferation, migration, and invasion and inhibits apoptosis in lung adenocarcinoma by targeting PTPRD. Int J Clin Exp Pathol. 12:4222–4231. 2019.PubMed/NCBI | |
|
Qin E, Gu S, Guo Y, Wang L and Pu G: MiRNA-30a-5p/VCAN arrests tumor metastasis via modulating the adhesion of lung adenocarcinoma cells. Appl Biochem Biotechnol. Apr 10–2023.(Epub ahead of print). View Article : Google Scholar | |
|
Tao K, Liu J, Liang J, Xu X, Xu L and Mao W: Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2. Carcinogenesis. 42:1056–1067. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang G, Wu YJ and Yan F: MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway. Eur Rev Med Pharmacol Sci. 23:9480–9488. 2019.PubMed/NCBI | |
|
Dai B, Kong DL, Tian J, Liu TW, Zhou H and Wang ZF: microRNA-1205 promotes cell growth by targeting APC2 in lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 23:1125–1133. 2019.PubMed/NCBI | |
|
Bai J, Hu Y, Chen X, Chen L, Zhang L, Yin C and Li H: miR-144-3p inhibits the invasion and metastasis of lung adenocarcinoma cells by targeting IRS1. Zhongguo Fei Ai Za Zhi. 24:323–330. 2021.(In Chinese). PubMed/NCBI | |
|
Liu K, Zhang W, Tan J, Ma J and Zhao J: MiR-200b-3p functions as an oncogene by targeting ABCA1 in lung adenocarcinoma. Technol Cancer Res Treat. 18:15330338198925902019. View Article : Google Scholar : PubMed/NCBI | |
|
Guo ZZ, Ma ZJ, He YZ, Jiang W, Xia Y, Pan CF, Wei K, Shi YJ, Chen L and Chen YJ: miR-550a-5p functions as a tumor promoter by targeting LIMD1 in lung adenocarcinoma. Front Oncol. 10:5707332020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Zhao J, Yin X, Yuan X, Guo J and Bi J: miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma. Cell Prolif. 49:636–643. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y and Yang C: miR-197-3p-induced downregulation of lysine 63 deubiquitinase promotes cell proliferation and inhibits cell apoptosis in lung adenocarcinoma cell lines. Mol Med Rep. 17:3921–3927. 2018.PubMed/NCBI | |
|
Fang H, Liu Y, He Y, Jiang Y, Wei Y, Liu H, Gong Y and An G: Extracellular vesicle-delivered miR-505-5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1. Int J Oncol. 54:1821–1832. 2019.PubMed/NCBI | |
|
Qian T, Shi S, Xie L and Zhu Y: miR-938 promotes cell proliferation by regulating RBM5 in lung adenocarcinoma cells. Cell Biol Int. 44:295–305. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cao J, Geng J, Chu X, Wang R, Huang G and Chen L: miRNA-885-3p inhibits docetaxel chemoresistance in lung adenocarcinoma by downregulating Aurora A. Oncol Rep. 41:1218–1230. 2019.PubMed/NCBI | |
|
Bao B, Yu X and Zheng W: MiR-139-5p targeting CCNB1 modulates proliferation, migration, invasion and cell cycle in lung adenocarcinoma. Mol Biotechnol. 64:852–860. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, He X, Wu X, Liu X, Huang Y and Gong Y: miR-139-5p inhibits lung adenocarcinoma cell proliferation, migration, and invasion by targeting MAD2L1. Comput Math Methods Med. 2020:29535982020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Zhou L, Chen B, Li X, Zou Q, Xu W, Fang L, Wu A, Li Z and Chen Y: microRNA-660 enhances cisplatin sensitivity via decreasing SATB2 expression in lung adenocarcinoma. Genes. 14:9112023. View Article : Google Scholar : PubMed/NCBI | |
|
Feng YY, Liu CH, Xue Y, Chen YY, Wang YL and Wu XZ: MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. Gene. 730:1443162020. View Article : Google Scholar : PubMed/NCBI | |
|
Wan S, Liu Z, Chen Y, Mai Z, Jiang M, Di Q and Sun B: MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase). Bioengineered. 12:11959–11977. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Kanmangne D, Li R, Qian Z, Xia X, Wang X and Wang T: miR-30a-3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2. Oncol Rep. 43:646–654. 2020.PubMed/NCBI | |
|
Chen L, Chen X, Liu L, Zhao Y, Zuo W, Yin C and Li H: miR-30b-3p inhibits the proliferation and invasion of lung adenocarcinoma by targeting COX6B1. Zhongguo Fei Ai Za Zhi. 25:567–574. 2022.(In Chinese). PubMed/NCBI | |
|
Tu Y and Mei F: miR-3648 promotes lung adenocarcinoma-genesis by inhibiting SOCS2 (suppressor of cytokine signaling 2). Bioengineered. 13:3044–3056. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Cui Y, Wang S, Wu C, Mei F, Han E, Hu Z and Zhou B: MiR-96-5p is an oncogene in lung adenocarcinoma and facilitates tumor progression through ARHGAP6 downregulation. J Appl Genet. 62:631–638. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou F, Qian C, Chen T and Zang X: MiR-96-5p facilitates lung adenocarcinoma cell phenotypes by inhibiting FHL1. Comput Math Methods Med. 2022:78912222022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen G, Wang Q and Wang K: MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha. Bioengineered. 13:10061–10070. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Miao H, Zeng Q, Xu S and Chen Z: miR-1-3p/CELSR3 participates in regulating malignant phenotypes of lung adenocarcinoma cells. Curr Gene Ther. 21:304–312. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li T, Wang X, Jing L and Li Y: MiR-1-3p inhibits lung adenocarcinoma cell tumorigenesis via targeting protein regulator of cytokinesis 1. Front Oncol. 9:1202019. View Article : Google Scholar : PubMed/NCBI | |
|
An JC, Shi HB, Hao WB, Zhu K and Ma B: miR-944 inhibits lung adenocarcinoma tumorigenesis by targeting STAT1 interaction. Oncol Lett. 17:3790–3798. 2019.PubMed/NCBI | |
|
Feng H, Zhang Z, Qing X, French SW and Liu D: miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN. Exp Mol Pathol. 108:105–113. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Q and Xu Z: miR-196b-5p promotes proliferation, migration and invasion of lung adenocarcinoma cells via targeting RSPO2. Cancer Manag Res. 12:13393–13402. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lin R, Li GS, Gan XY, Peng JX, Feng Y, Wang LT, Zhang CY, Huang KY, Huang SH, Yang L, et al: The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma. Technol Health Care. 31:1691–1707. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Goto A, Tanaka M, Yoshida M, Umakoshi M, Nanjo H, Shiraishi K, Saito M, Kohno T, Kuriyama S, Konno H, et al: The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases. PLoS One. 12:e01812702017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang G, Zhou Y, Chen W, Yang Y, Ye J, Ou H and Wu H: miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2. Cancer Biomark. 28:549–559. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wei D: MiR-486-5p specifically suppresses SAPCD2 expression, which attenuates the aggressive phenotypes of lung adenocarcinoma cells. Histol Histopathol. 37:909–917. 2022.PubMed/NCBI | |
|
Yang W, Bai J, Liu D, Wang S, Zhao N, Che R and Zhang H: MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis. Gene. 647:13–20. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Shao L, He Q, Wang J, He F, Lin S, Wu L, Gao Y, Ma W, Dong J, Yang X and Li F: MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3. Cell Death Discov. 7:1452021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao J, Yu H, Han T and Zhu X: Prognosis value of microRNA-3677-3p in lung adenocarcinoma and its regulatory effect on tumor progression. Cancer Manag Res. 13:9261–9270. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ling DJ, Chen ZS, Zhang YD, Liao QD, Feng JX, Zhang XY and Shi TS: MicroRNA-145 inhibits lung cancer cell metastasis. Mol Med Rep. 11:3108–3114. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang HB, Shen B, Ma ZC, Xu YY, Lou YL and Chen M: MiR-593-5p inhibited proliferation and migration of lung adenocarcinoma by targeting ICAM-1. Eur Rev Med Pharmacol Sci. 24:4298–4305. 2020.PubMed/NCBI | |
|
Huang JY, Cui SY, Chen YT, Song HZ, Huang GC, Feng B, Sun M, De W, Wang R and Chen LB: MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression. PLoS One. 8:e726152013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhuo E, Cai C, Liu W, Li K and Zhao W: Downregulated microRNA-140-5p expression regulates apoptosis, migration and invasion of lung cancer cells by targeting zinc finger protein 800. Oncol Lett. 20:3902020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Xiao H, Wu D, Zhang D and Zhang Z: miR-335-5p regulates cell cycle and metastasis in lung adenocarcinoma by targeting CCNB2. Onco Targets Ther. 13:6255–6263. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Heikkinen L, Wang C, Yang Y, Sun H and Wong G: Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 20:1836–1852. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Petkova V, Marinova D, Kyurkchiyan S, Stancheva G, Mekov E, Kachakova-Yordanova D, Slavova Y, Kostadinov D, Mitev V and Kaneva R: MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs. Medicine (Baltimore). 101:e300272022. View Article : Google Scholar : PubMed/NCBI | |
|
Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, et al: Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing. Clin Cancer Res. 23:5311–5319. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 17:1472018. View Article : Google Scholar : PubMed/NCBI | |
|
Rupaimoole R and Slack FJ: MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Saliminejad K, Khorram Khorshid HR, Soleymani Fard S and Ghaffari SH: An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 234:5451–5465. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Seijo LM, Peled N, Ajona D, Boeri M, Field JK, Sozzi G, Pio R, Zulueta JJ, Spira A, Massion PP, et al: Biomarkers in lung cancer screening: Achievements, promises, and challenges. J Thorac Oncol. 14:343–357. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kim Y, Sim J, Kim H, Bang SS, Jee S, Park S and Jang K: MicroRNA-374a expression as a prognostic biomarker in lung adenocarcinoma. J Pathol Transl Med. 53:354–360. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Tong L, Han WZ, Wang JL, Sun NN and Zhuang M: MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway. Eur Rev Med Pharmacol Sci. 24:4836–4845. 2020.PubMed/NCBI | |
|
Kim Y, Kim H, Bang S, Jee S and Jang K: MicroRNA-130b functions as an oncogene and is a predictive marker of poor prognosis in lung adenocarcinoma. Lab Invest. 101:155–164. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Mei H, Xu C, Tang H and Wei W: Circulating microRNA-339-5p and −21 in plasma as an early detection predictors of lung adenocarcinoma. Pathol Res Pract. 214:119–125. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Li X and Wu X: MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7. Onco Targets Ther. 11:8445–8454. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Li X, Yang L and Zhang J: Long non-coding RNA LINC01969 promotes ovarian cancer by regulating the miR-144-5p/LARP1 axis as a competing endogenous RNA. Front Cell Dev Biol. 8:6257302021. View Article : Google Scholar : PubMed/NCBI | |
|
Perlikos F, Harrington KJ and Syrigos KN: Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review. Crit Rev Oncol Hematol. 87:1–11. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Verma V and Lautenschlaeger T: MicroRNAs in non-small cell lung cancer invasion and metastasis: From the perspective of the radiation oncologist. Expert Rev Anticancer Ther. 16:767–774. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Pastushenko I and Blanpain C: EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bukowski K, Kciuk M and Kontek R: Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 21:32332020. View Article : Google Scholar : PubMed/NCBI | |
|
Baskar R, Lee KA, Yeo R and Yeoh KW: Cancer and radiation therapy: Current advances and future directions. Int J Med Sci. 9:193–199. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mishra S, Yadav T and Rani V: Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang N, Zou C, Zhu Y, Luo Y, Chen L, Lei Y, Tang K, Sun Y, Zhang W, Li S, et al: HIF-1α-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling. Theranostics. 10:2553–2570. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Du X, Wang S, Liu X, He T, Lin X, Wu S, Wang D, Li J, Huang W and Yang H: MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferation. Cancer Cell Int. 20:5022020. View Article : Google Scholar : PubMed/NCBI | |
|
He T, Shen H, Wang S, Wang Y, He Z, Zhu L, Du X, Wang D, Li J, Zhong S, et al: MicroRNA-3613-5p promotes lung adenocarcinoma cell proliferation through a RELA and AKT/MAPK positive feedback loop. Mol Ther Nucleic Acids. 22:572–583. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ma DB, Qin MM, Shi L and Ding XM: MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway. Cell Signal. 64:1093912019. View Article : Google Scholar : PubMed/NCBI | |
|
Song M and Xing X: miR-6742-5p regulates the invasion and migration of lung adenocarcinoma cells via mediating FGF8/ERK12/MMP9/MMP2 signaling pathway. Aging (Albany NY). 15:53–69. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Fang H, Wu W and Wu Z: miR-382-3p downregulation contributes to the carcinogenesis of lung adenocarcinoma by promoting AKT SUMOylation and phosphorylation. Exp Ther Med. 24:4402022. View Article : Google Scholar : PubMed/NCBI | |
|
Lin Q: MicroRNA-1-3p affects lung adenocarcinoma progression through E2F8 and regulating NF-кB pathway. Cytokine. 156:1559222022. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Liu W, Zhao Q, Zhang R, Wang J, Pan P, Shang H, Liu C and Wang C: Down-regulating the expression of miRNA-21 inhibits the glucose metabolism of A549/DDP cells and promotes cell death through the PI3K/AKT/mTOR/HIF-1α pathway. Front Oncol. 11:6535962021. View Article : Google Scholar : PubMed/NCBI | |
|
Edmonds MD, Boyd KL, Moyo T, Mitra R, Duszynski R, Arrate MP, Chen X, Zhao Z, Blackwell TS, Andl T and Eischen CM: MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. J Clin Invest. 126:349–364. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Qu J, Li M, An J, Zhao B, Zhong W, Gu Q, Cao L, Yang H and Hu C: MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling. Int J Oncol. 47:2141–2152. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Zhang Y, Li Y, Liu L, Li Z, Liu Y and Xiao Y: MicroRNA-106a-5p promotes the proliferation, autophagy and migration of lung adenocarcinoma cells by targeting LKB1/AMPK. Exp Ther Med. 22:14222021. View Article : Google Scholar : PubMed/NCBI | |
|
Fan X, Liang Y, Liu Y, Bai Y, Yang C and Xu S: The upregulation of TMPRSS4, partly ascribed to the downregulation of miR-125a-5p, promotes the growth of human lung adenocarcinoma via the NF-κB signaling pathway. Int J Oncol. 53:148–158. 2018.PubMed/NCBI | |
|
Ghoshal-Gupta S, Kutiyanawalla A, Lee BR, Ojha J, Nurani A, Mondal AK, Kolhe R, Rojiani AM and Rojiani MV: TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway. Oncotarget. 9:8941–8956. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Meng H, Li B, Xu W, Ding R, Xu S, Wu Q and Zhang Y: miR-140-3p enhances the sensitivity of LUAD cells to antitumor agents by targeting the ADAM10/Notch pathway. J Cancer. 13:3660–3673. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang WS, Huang CL, Zhang J, Xu F and Dai XH: MicroRNA-149 inhibits the progression of lung adenocarcinoma through targeting RAP1B and inactivating Wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci. 24:4846–4854. 2020.PubMed/NCBI | |
|
Liu J, Xing Y and Rong L: miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway. Oncol Rep. 39:1631–1639. 2018.PubMed/NCBI | |
|
Seidl C, Panzitt K, Bertsch A, Brcic L, Schein S, Mack M, Leithner K, Prinz F, Olschewski H, Kornmueller K and Hrzenjak A: MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2. Cancer Lett. 469:266–276. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Guo L, Wang J, Yang P, Lu Q, Zhang T and Yang Y: MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation. IUBMB Life. 67:720–725. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Gao X, Zhang W, Zhu T, Bi W and Zhang Y: MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway. IUBMB Life. 70:81–91. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Watt K, Newsted D, Voorand E, Gooding RJ, Majewski A, Truesdell P, Yao B, Tuschl T, Renwick N and Craig AW: MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma. Cell Signal. 50:25–36. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lv Q, Hu JX, Li YJ, Xie N, Song DD, Zhao W, Yan YF, Li BS, Wang PY and Xie SY: MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals. Cancer Biol Ther. 18:142–151. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou QY, Gui SY, Zhang P and Wang M: Upregulation of miR-345-5p suppresses cell growth of lung adenocarcinoma by regulating ras homolog family member A (RhoA) and Rho/Rho associated protein kinase (Rho/ROCK) pathway. Chin Med J (Engl). 134:2619–2628. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Chen T, Huang H, Jiang Y, Yang L, Lin Z, He H, Liu T, Wu B, Chen J, et al: miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma. Oncotarget. 8:20133–20144. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Zhang S, Bao H, Mu S, Zhang B, Ma H and Ma S: MicroRNA-365 promotes lung carcinogenesis by downregulating the USP33/SLIT2/ROBO1 signalling pathway. Cancer Cell Int. 18:642018. View Article : Google Scholar : PubMed/NCBI | |
|
Xuan YW, Liao M, Zhai WL, Peng LJ and Tang Y: MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. Eur Rev Med Pharmacol Sci. 23:8411–8421. 2019.PubMed/NCBI | |
|
He B, Wu C, Sun W, Qiu Y, Li J, Liu Z, Jing T, Wang H and Liao Y: miR-383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24-mediated NF-κB signaling pathway. Int J Oncol. 59:872021. View Article : Google Scholar : PubMed/NCBI | |
|
Wan L, Zhu L, Xu J, Lu B, Yang Y, Liu F and Wang Z: MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met. Cell Physiol Biochem. 34:1273–1290. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ma J, Huang W, Zhu C, Sun X, Zhang Q, Zhang L, Qi Q, Bai X, Feng Y and Wang C: miR-423-3p activates FAK signaling pathway to drive EMT process and tumor growth in lung adenocarcinoma through targeting CYBRD1. J Clin Lab Anal. 35:e240442021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu R, Wang F, Guo Y, Yang J, Chen S, Gao X and Wang X: MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9). Onco Targets Ther. 11:4065–4073. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen D, Huang J, Zhang K, Pan B, Chen J, De W, Wang R and Chen L: MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc. Eur J Cancer. 50:3050–3067. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Jiang D and Yang S: MiR-490-3p inhibits the malignant progression of lung adenocarcinoma. Cancer Manag Res. 12:10975–10984. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Duan J, Wang L, Shang L, Yang S, Wu H, Huang Y and Miao Y: miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway. Biosci Rep. 41:BSR202015392021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhijun Z and Jingkang H: MicroRNA-520e suppresses non-small-cell lung cancer cell growth by targeting Zbtb7a-mediated Wnt signaling pathway. Biochem Biophys Res Commun. 486:49–56. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang Z, Zhang J, Chen F and Sun Y: MiR-148b suppressed non-small cell lung cancer progression via inhibiting ALCAM through the NF-κB signaling pathway. Thorac Cancer. 11:415–425. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang W, Wei K, Pan C, Li H, Cao J, Han X, Tang Y, Zhu S, Yuan W, He Y, et al: MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer. Cell Prolif. 51:e125022018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu T, Hu H, Zhang T, Jiang L, Li X, Liu S, Zheng C, Yan G, Chen W, Ning Y, et al: miR-25 promotes cell proliferation, migration, and invasion of non-small-cell lung cancer by targeting the LATS2/YAP signaling pathway. Oxid Med Cell Longev. 2019:97197232019. View Article : Google Scholar : PubMed/NCBI | |
|
Ding X, Zhong T, Jiang L, Huang J, Xia Y and Hu R: miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4. Mol Med Rep. 17:7005–7016. 2018.PubMed/NCBI | |
|
Hu Z, Xiao D, Qiu T, Li J and Liu Z: MicroRNA-103a curtails the stemness of non-small cell lung cancer cells by binding OTUB1 via the hippo signaling pathway. Technol Cancer Res Treat. 19:15330338209716432020. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang K, Shen M, Chen Y and Xu W: miR-150 promotes the proliferation and migration of non-small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway. Oncol Rep. 40:943–951. 2018.PubMed/NCBI | |
|
Xu G, Cai J, Wang L, Jiang L, Huang J, Hu R and Ding F: MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling. Exp Cell Res. 362:268–278. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang JX, Zhai JF, Yang XT and Wang J: MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 20:3793–3801. 2016.PubMed/NCBI | |
|
Revathidevi S and Munirajan AK: Akt in cancer: Mediator and more. Semin Cancer Biol. 59:80–91. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ward SG, Westwick J and Harris S: Sat-Nav for T cells: Role of PI3K isoforms and lipid phosphatases in migration of T lymphocytes. Immunol Lett. 138:15–18. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Altomare DA and Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Akbarzadeh M, Mihanfar A, Akbarzadeh S, Yousefi B and Majidinia M: Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer. Life Sci. 285:1199842021. View Article : Google Scholar : PubMed/NCBI | |
|
Zou S, Tong Q, Liu B, Huang W, Tian Y and Fu X: Targeting STAT3 in Cancer Immunotherapy. Mol Cancer. 19:1452020. View Article : Google Scholar : PubMed/NCBI | |
|
Johnson DE, O'Keefe RA and Grandis JR: Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 15:234–248. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhan T, Rindtorff N and Boutros M: Wnt signaling in cancer. Oncogene. 36:1461–1473. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang S: mTOR signaling in metabolism and cancer. Cells. 9:22782020. View Article : Google Scholar : PubMed/NCBI | |
|
Hua H, Kong Q, Zhang H, Wang J, Luo T and Jiang Y: Targeting mTOR for cancer therapy. J Hematol Oncol. 12:712019. View Article : Google Scholar : PubMed/NCBI | |
|
Kryczka J, Kryczka J, Czarnecka-Chrebelska KH and Brzeziańska-Lasota E: Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy. Int J Mol Sci. 22:88852021. View Article : Google Scholar : PubMed/NCBI | |
|
Dolcet X, Llobet D, Pallares J and Matias-Guiu X: NF-kB in development and progression of human cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Bonizzi G and Karin M: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280–288. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lee S, Rauch J and Kolch W: Targeting MAPK signaling in cancer: Mechanisms of drug resistance and sensitivity. Int J Mol Sci. 21:11022020. View Article : Google Scholar : PubMed/NCBI | |
|
Asl ER, Amini M, Najafi S, Mansoori B, Mokhtarzadeh A, Mohammadi A, Lotfinejad P, Bagheri M, Shirjang S, Lotfi Z, et al: Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression. Life Sci. 278:1194992021. View Article : Google Scholar : PubMed/NCBI | |
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and Ma W: ceRNA in cancer: Possible functions and clinical implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Arancio W, Pizzolanti G, Genovese SI, Baiamonte C and Giordano C: Competing endogenous RNA and interactome bioinformatic analyses on human telomerase. Rejuvenation Res. 17:161–167. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yang S, Liu T, Sun Y and Liang X: The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p. Cell Mol Biol Lett. 24:702019. View Article : Google Scholar : PubMed/NCBI | |
|
Qian Y, Zhang Y, Ji H, Shen Y, Zheng L, Cheng S and Lu X: LINC01089 suppresses lung adenocarcinoma cell proliferation and migration via miR-301b-3p/STARD13 axis. BMC Pulm Med. 21:2422021. View Article : Google Scholar : PubMed/NCBI | |
|
Cai Y, Sheng Z, Chen Y and Wang J: LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis. Aging (Albany NY). 11:3041–3054. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Li X, Du B, Cui Y, Ma Y and Li Y: The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis. Cancer Med. 12:4421–4433. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Chen H, Liu M, Xiong J and Song Z: Long noncoding RNA LINC00520 accelerates lung adenocarcinoma progression via miR-1252-5p/FOXR2 pathway. Hum Cell. 34:478–490. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Li W, Lin Z, Hu J, Wang J, Ren Y, Wei B, Fan Y and Yang Y: The long noncoding RNA Linc01833 enhances lung adenocarcinoma progression via MiR-519e-3p/S100A4 axis. Cancer Manag Res. 12:11157–11167. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Dong HX, Wang R, Jin XY, Zeng J and Pan J: LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p. J Cell Physiol. 233:4126–4136. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bai J, Li H, Chen X, Chen L, Hu Y, Liu L, Zhao Y, Zuo W, Zhang B and Yin C: LncRNA-AC009948.5 promotes invasion and metastasis of lung adenocarcinoma by binding to miR-186-5p. Front Oncol. 12:9499512022. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Yu Q, Zhou Y, Chu Y, Jiang F and Wang Q: FAM201A knockdown inhibits proliferation and invasion of lung adenocarcinoma cells by regulating miR-7515/GLO1 axis. J Cell Physiol. 236:5620–5632. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ge Z, Liu H, Ji T, Liu Q, Zhang L, Zhu P, Li L and Zhu L: Long non-coding RNA 00960 promoted the aggressiveness of lung adenocarcinoma via the miR-124a/SphK1 axis. Bioengineered. 13:1276–1287. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Tai G, Fu H, Bai H, Liu H, Li L and Song T: Long non-coding RNA GLIDR accelerates the tumorigenesis of lung adenocarcinoma by miR-1270/TCF12 axis. Cell Cycle. 20:1653–1662. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Mu X, Wu H, Liu J, Hu X, Wu H, Chen L, Liu W, Luo S and Zhao Y: Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p. Biomed Pharmacother. 125:1099892020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu T, Yang C, Wang W and Liu C: LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis. Thorac Cancer. 12:2104–2112. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Q, Xu Z, Zhu K, Lin J and Ye B: LINC00346 sponges miR-30c-2-3p to promote the development of lung adenocarcinoma by targeting MYBL2 and regulating CELL CYCLE signaling pathway. Front Oncol. 11:6872082021. View Article : Google Scholar : PubMed/NCBI | |
|
Yao Y, Hua Q and Zhou Y: CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun. 508:37–45. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Du J, Zhang G, Qiu H, Yu H and Yuan W: The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway. Cell Mol Biol Lett. 24:722019. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Su S, Ye D, Yu Z, Lu W and Liu L: Hsa_circ_0020850 promotes the malignant behaviors of lung adenocarcinoma by regulating miR-326/BECN1 axis. World J Surg Oncol. 20:132022. View Article : Google Scholar : PubMed/NCBI | |
|
Ma D, Liu H, Qin Y, Li D, Cui Y, Li L, He J, Chen Y and Zhou X: Circ_0007142/miR-186/FOXK1 axis promoted lung adenocarcinoma progression. Am J Transl Res. 12:4728–4738. 2020.PubMed/NCBI | |
|
Huang C, Yue W, Li L, Li S, Gao C, Si L, Qi L, Cheng C, Lu M, Chen G, et al: Circular RNA hsa-circ-000881 suppresses the progression of lung adenocarcinoma in vitro via a miR-665/PRICKLE2 axis. Ann Transl Med. 9:4982021. View Article : Google Scholar : PubMed/NCBI | |
|
Shi Q and Ju JG: Circ_0001998 regulates the proliferation, invasion, and apoptosis of lung adenocarcinoma via sponging miR-145. Evid Based Complement Alternat Med. 2022:64461502022.PubMed/NCBI | |
|
Fan J, Xia X and Fan Z: Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma. J Clin Lab Anal. 36:e245912022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang B, Chen M, Jiang N, Shi K and Qian R: A regulatory circuit of circ-MTO1/miR-17/QKI-5 inhibits the proliferation of lung adenocarcinoma. Cancer Biol Ther. 20:1127–1135. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wei W, Wang C, Wang L and Zhang J: circ_0020123 promotes cell proliferation and migration in lung adenocarcinoma via PDZD8. Open Med (Wars). 17:536–549. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Z: Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling. Life Sci. 259:1181572020. View Article : Google Scholar : PubMed/NCBI | |
|
Cao F, Liu S, Li Z, Meng L, Sang M and Shan B: Activation of circ_0072088/miR-1261/PIK3CA pathway accelerates lung adenocarcinoma progression. Thorac Cancer. 13:1548–1557. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Panda AC: Circular RNAs Act as miRNA sponges. Adv Exp Med Biol. 1087:67–79. 2018. View Article : Google Scholar : PubMed/NCBI |
